Molekule Group falls on wider Q2 loss
** Shares of pathogen elimination technology company
Molekule Group MKUL.O down 7.9% at $1.64
** Company reports Q2 loss of 76 cents per share vs 37 cents
per share loss a year ago
** MKUL sees revenue for second half of 2023 at $28.5
mln-$33.5 mln
** Shares down ~50% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Molekule
See all newsBrief: Molekule Group Inc Received Notice From Nasdaq Notifying Delisting of Common Stock
Brief: Molekule Group Says Co, Molekule Inc Failed To Maintain Unrestricted And Unencumbered Cash With Svb Of At Least $2 Mln, Event Of Default Under Loan Deals
Brief: Molekule Group Inc On September 18 Commenced A Plan To Reduce Company's Headcount By Approximately 15%
Brief: Molekule Group Says It Is Exploring Various Capital Raising Opportunities, Including Rights Offering
U.S. STOCKS ON THE MOVE-Nu Holdings, United States Steel, Mallinckrodt